PACS Group, Inc. announced its operating results for the third quarter of 2025, showcasing significant growth in revenue and net income.
The company completed the restatement of its financial statements for previous periods and is now compliant with SEC filing obligations.
Key performance indicators like skilled nursing portfolio ratings and facility occupancy demonstrate the company's operational strength.
Revenue Growth
Revenue increased by 31.0% in the third quarter of 2025, reaching $1.34 billion.
Strategic Focus
PACS remains committed to its mission of revolutionizing post-acute care through clinical excellence and sustainable growth strategies.
Financial Stability
With net income of $131.7 million year-to-date, PACS shows strong financial performance.
Guidance for 2025
The company expects revenue between $5.25 billion to $5.35 billion and adjusted EBITDA in the range of $480 million to $490 million for the full year 2025.
- PACS's strong results validate the effectiveness of its business model and operational execution.
- Completion of the restatement and audit committee investigations positions the company with a solid financial foundation for future growth.
PACS Group, Inc.'s performance in the third quarter of 2025 underscores its commitment to quality care and sustainable growth, with a positive outlook for the full year. The company's focus on operational excellence and financial stability sets a solid foundation for creating long-term value for shareholders.